Jove
Visualize
Contact Us

Related Concept Videos

Vaccine Production01:23

Vaccine Production

34
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
34
Vaccines01:21

Vaccines

41
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
41
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Development of Immunocompetence01:22

Development of Immunocompetence

1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Vaccinations01:51

Vaccinations

53.6K
Overview
53.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of <i>Clostridioides difficile</i> Infections in Republic of Korea: A Prospective Study With Active Surveillance vs. National Data From Health Insurance Review & Assessment Service.

Journal of Korean medical science·2024
Same author

Epidemiology and Clinical Characteristics of Zika Virus Infections Imported into Korea from March to October 2016.

Journal of Korean medical science·2017
Same journal

Determinants of HPV vaccine hesitancy in South Asia: a systematic review.

Clinical and experimental vaccine research·2026
Same journal

Vaccine development against <i>Mycobacterium tuberculosis</i>: a PRISMA-guided systematic review of conventional and computational multi-epitope approaches.

Clinical and experimental vaccine research·2026
Same journal

Pharmaceutical design of mRNA vaccines for endemic infectious diseases: integrating antigen discovery with platform engineering.

Clinical and experimental vaccine research·2026
Same journal

Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study.

Clinical and experimental vaccine research·2026
Same journal

Varicella zoster virus infection and reactivation in a psychiatric ward during the COVID-19 pandemic: a case series analysis.

Clinical and experimental vaccine research·2026
Same journal

Survival after primary and booster COVID-19 vaccination in patients with COPD.

Clinical and experimental vaccine research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 26, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K

Recent update in HIV vaccine development.

So Youn Shin1

  • 1Department of Infectious Diseases, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.

Clinical and Experimental Vaccine Research
|February 12, 2016
PubMed
Summary
This summary is machine-generated.

Developing an effective human immunodeficiency virus (HIV) vaccine remains challenging. Understanding immune protection correlates is key to advancing novel HIV vaccine strategies and overcoming past trial disappointments.

Keywords:
CorrelatesHIVPreventionVaccines

More Related Videos

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.3K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.8K

Related Experiment Videos

Last Updated: Mar 26, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.3K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • Developing a human immunodeficiency virus (HIV) vaccine has faced significant challenges, with past clinical trials yielding disappointing results.
  • Key trials like VaxGen's AIDSVAXgp120 and MRKAd5 HIV-1 Gag/Pol/Nef highlighted the need to understand immune protection correlates.
  • The RV144 trial, despite modest efficacy, provided crucial insights into correlates of risk, revitalizing HIV vaccine research.

Purpose of the Study:

  • To review the historical development of HIV vaccine research.
  • To discuss recent advancements and novel strategies in the field.
  • To emphasize the importance of understanding immune correlates for future vaccine success.

Main Methods:

  • Literature review of historical HIV vaccine trials.
  • Analysis of findings from significant clinical trials (e.g., RV144).
  • Discussion of emerging strategies based on correlate of risk analysis.

Main Results:

  • Previous HIV vaccine candidates have shown limited success.
  • Understanding correlates of immune protection is critical for HIV vaccine development.
  • Recent research, spurred by trials like RV144, is exploring new vaccine approaches.

Conclusions:

  • The path to an effective HIV vaccine is complex and ongoing.
  • Correlates of immune protection are central to solving the HIV vaccine puzzle.
  • Novel strategies are emerging, offering renewed hope in HIV vaccine research.